规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
g | ¥ đųȃǦǦ | > 0 | > 0 | ¥ đųȃǦǦ | - + | ||||
5g | ¥ ƄĪȃǦǦ | > 0 | 5 | 3 | 4 | 3 | ¥ ƄĪȃǦǦ | - + | |
0g | ¥ ĪǦĪȃǦǦ | > 0 | -- | 5 | 8 | ¥ ĪǦĪȃǦǦ | - + | ||
5g | ¥ ððĉȃǦǦ | > 0 | 3 | 5 | 6 | 3 | ¥ ððĉȃǦǦ | - + | |
00g | ¥ ȎǦųȃǦǦ | > 0 | -- | 3 | 4 | ¥ ȎǦųȃǦǦ | - + | ||
500g | ¥ ųƄĪƄȃǦǦ | 3 | -- | -- | -- | ¥ ųƄĪƄȃǦǦ | - + | ||
kg | ¥ NjNjȎŧȃǦǦ | -- | -- | -- | -- | -- | ¥ NjNjȎŧȃǦǦ | - + | |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
49.33
[]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 07;6(5):35-337.
[]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 00;7(8):998-985.
[3]. G Johnson, et al. Beta-proline analogues as agonists at the strychnine-sensitive glycine receptor. J Med Chem. 99 Jan 4;35():33-4.
H30-H35-H39-H335
P6-P64-P70-P7-P80-P30+P35-P304+P340-P305+P35+P338-P330-P36+P364-P403+P33-P405-P50